Market Research Insights

San Francisco, 22 May 2019:  The Report  North America OTC Hyaluronic Acid (HA) Market  Analysis By Product (Dermatology (Moisturizers, Anti-Wrinkle), Orthopedic), By Sales Channels (Retail Chain, Online Channels), By Country (U.S., Canada), And Segment Forecasts, 2018 – 2024 The North America OTC Hyaluronic Acid (HA) Market is expected to reach a value of USD 41.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth. Orthopedic applications of HA are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In ad

San Francisco, 22 May 2019:  The Report   Knee Implants Market  Analysis By Procedure Type (Total, Partial, Revision Knee Replacement), By Component Type (Fixed-Bearing, Mobile-Bearing Implants), And Segment Forecasts To 2024 The global Knee Implants Market was valued at USD 8.8 billion in 2015 and is expected to reach a value of USD 12.4 billion by 2024. This growth is majorly attributed to growing elderly population and surging prevalence of chronic rheumatic conditions such as osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis. Primary factors that lead to the occurrence of arthritis are aging, physical injuries, genetic inheritance factors, abnormal metabolism, infections, and immune system abnormalities. Introduction of advanced technologies and products for are anticipated to keep the industry rivalry and market growth at par over the forecast period. For example, X3 Advanced Bearing Technology and Mako Robotic-Arm Assisted Technology with capabilities of pro

San Francisco, 21 May 2019:  The Report  Clot Management Devices Market  Analysis By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis Devices), By End User, And Segment Forecasts 2018 – 2024 The global Clot Management Devices Market was valued at USD 1.26 billion in 2015 and is further expected to reach a value of USD 1.88 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to grow with a CAGR of 4.6% owing to the key drivers such as increasing prevalence of stroke, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), obesity, growing geriatric population, technological advancements, and improvement in health insurance coverage & availability of emergency medical services. Globally, the number of people impacted by PE and DVT, which are collectively known as Venous Thromboembolism (VTE), is much larger than AIDS, cancer, and road traffic accide

San Francisco, 21 May 2019:  The Report  Transplant Diagnostics Market  Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 – 2024 The global Transplant Diagnostics Market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics. Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic method

San Francisco, 21 May 2019:  The Report  Congestive Heart Failure (CHF) Treatment Devices Market  Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024 The Congestive Heart Failure (CHF) Treatment Devices Market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs. Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist

San Francisco, 21 May 2019:  The Report  Biological Implants Market  Size And Forecast By Product (Autografts, Allografts, Xenografts), By Application (Cardiovascular Orthopedic, Dental, & Dermal Implants), By Mode Of Administration (Injectable & Surgical)’ And Trend Analysis From 2018 To 2024 Global Biological Implants Market is anticipated to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus

San Francisco, 21 May 2019:  The Report  Neurostimulation Devices Market  Size, Share & Trend Analysis By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator), By Application, And Segment Forecasts, 2018 – 2024 The Neurostimulation Devices Market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent device approval regulations are expected to hamper the growth. Apart from the above mentioned factors, increasing incidence